Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance

Published on May 9, 2018in Tumori1.707
· DOI :10.5301/TJ.5000646
Maria Francesca Alvisi5
Estimated H-index: 5
,
Claudia Repetto17
Estimated H-index: 17
+ 9 AuthorsLara Bellardita10
Estimated H-index: 10
Sources
Abstract
Purpose:The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) is a self-report questionnaire that was developed in English to assess prostate cancer (PCa)-related anxiety. The aim of this study w...
References24
Newest
#1Silvia VillaH-Index: 6
#2Friederike KendelH-Index: 16
Last. Lara BellarditaH-Index: 10
view all 19 authors...
Abstract Background Literature on the health-related quality of life (HRQoL) for men with localized prostate cancer (PCa) on active surveillance (AS) shows a need for methodological guidance regarding HRQoL issues and how to address them. Objective The European School of Oncology Task Force (ESO TF) aimed to identify a core set of research questions and related measures to include in AS HRQoL studies. Design, setting, and participants A modified Delphi study was used to reach consensus on AS HRQ...
8 CitationsSource
#1Claudia Repetto (CUA: The Catholic University of America)H-Index: 17
#2Tiziana RancatiH-Index: 27
Last. Lara BellarditaH-Index: 10
view all 14 authors...
PurposeTo investigate the presence of regret in patients about having followed an active surveillance (AS) protocol. The secondary aim was to identify variables that influence regret.MethodsFrom February 2006 to May 2014, 204 patients discontinued the AS protocols and were invited to enter the study. Sociodemographic variables were collected at AS enrollment, together with health-related quality of life (Functional Assessment of Cancer Therapy-Prostate version [FACT-P]) and coping (Mini-Mental A...
3 CitationsSource
#1Leonard P. Bokhorst (Erasmus University Medical Center)H-Index: 12
#2Ries KranseH-Index: 37
Last. Monique J. Roobol (Erasmus University Medical Center)H-Index: 76
view all 8 authors...
Abstract Screening for prostate cancer (PCa) results in a favorable stage shift. However, even if screening did not result in a clinically apparent lower stage or grade, it might still lead to less disease recurrence after treatment with curative intent (radical prostatectomy [RP] and radiation therapy [RT]) because the tumor had less time to develop outside the prostate. The outcome after treatment could also differ because of variations in treatment quality (eg, radiation dosage/adjuvant hormo...
13 CitationsSource
#1Ridwan Alam (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 11
#2H. Ballentine Carter (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 79
Last. Mufaddal Mamawala (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 13
view all 5 authors...
Purpose: We evaluated the risk of prostate cancer reclassification by time on active surveillance.Materials and Methods: From 1995 to 2014 we evaluated 557 and 251 men at very low and at low risk, respectively, who were on active surveillance and compliant with prostate biopsies. Our primary study outcome was reclassification to higher risk disease by grade or extent. Freedom from reclassification was estimated using the Kaplan-Meier approach with adjustment for covariates using the Cox proporti...
29 CitationsSource
#1Chris H. Bangma (EUR: Erasmus University Rotterdam)H-Index: 78
#2Riccardo ValdagniH-Index: 51
Last. Jonas Hugosson (University of Gothenburg)H-Index: 67
view all 6 authors...
Active surveillance (AS) for low-risk prostate cancer (PCa) is attracting increased scientific interest due to better understanding of the natural course of PCa and to rapid technological developments in the diagnosis and treatment of early disease. There is no consensus on the optimal method of selecting men for AS with traditional markers and the role of new histologic, proteomic, or genetic markers. The role of new imaging modalities also remains unclear. The measurement of quality of life, t...
23 CitationsSource
#1Laurence Klotz (U of T: University of Toronto)H-Index: 85
#2Danny Vesprini (U of T: University of Toronto)H-Index: 33
Last. Andrew Loblaw (U of T: University of Toronto)H-Index: 35
view all 9 authors...
Purpose Active surveillance is increasingly accepted as a treatment option for favorable-risk prostate cancer. Long-term follow-up has been lacking. In this study, we report the long-term outcome of a large active surveillance protocol in men with favorable-risk prostate cancer. Patients and Methods In a prospective single-arm cohort study carried out at a single academic health sciences center, 993 men with favorable- or intermediate-risk prostate cancer were managed with an initial expectant a...
692 CitationsSource
#1John Graham (Cardiff University)H-Index: 5
#1John D. Graham (Cardiff University)H-Index: 42
Last. Matthew Prettyjohns (Cardiff University)H-Index: 4
view all 5 authors...
Prostate cancer poses a major health problem in many countries and is the commonest cancer in men in the UK.1 Its incidence and mortality rate are higher in men of African-Caribbean origin. Since publication of the original NICE guideline in 2008,2 there have been several changes in diagnosis and management of prostate cancer. Great improvements in the treatment of hormone relapsed metastatic disease with the introduction of several new treatments (cabazitaxel, abiraterone, enzalutamide, and rad...
80 CitationsSource
#1Axel Heidenreich (RWTH Aachen University)H-Index: 72
#2Patrick J. BastianH-Index: 51
Last. Nicolas MottetH-Index: 40
view all 11 authors...
Abstract Context The most recent summary of the European Association of Urology (EAU) guidelines on prostate cancer (PCa) was published in 2011. Objective To present a summary of the 2013 version of the EAU guidelines on screening, diagnosis, and local treatment with curative intent of clinically organ-confined PCa. Evidence acquisition A literature review of the new data emerging from 2011 to 2013 has been performed by the EAU PCa guideline group. The guidelines have been updated, and levels of...
1,404 CitationsSource
#1Lara BellarditaH-Index: 10
#2Tiziana RancatiH-Index: 27
Last. Riccardo ValdagniH-Index: 51
view all 11 authors...
Abstract Background Active surveillance (AS) is emerging as an alternative approach to limit the risk of overtreatment and impairment of quality of life (QoL) in patients with low-risk localised prostate cancer. Although most patients report high levels of QoL, some men may be distressed by the idea of living with untreated cancer. Objective To identify factors associated with poor QoL during AS. Design, setting, and participants Between September 2007 and March 2012, 103 patients participated i...
72 CitationsSource
#1Meelan Bul (EUR: Erasmus University Rotterdam)H-Index: 11
#1Samir S. Taneja (EUR: Erasmus University Rotterdam)H-Index: 1
Last. Monique J. Roobol (EUR: Erasmus University Rotterdam)H-Index: 29
view all 20 authors...
Abstract Background Overdiagnosis and subsequent overtreatment are important side effects of screening for, and early detection of, prostate cancer (PCa). Active surveillance (AS) is of growing interest as an alternative to radical treatment of low-risk PCa. Objective To update our experience in the largest worldwide prospective AS cohort. Design, setting, and participants Eligible patients had clinical stage T1/T2 PCa, prostate-specific antigen (PSA) ≤10 ng/ml, PSA density Reclassification was ...
367 CitationsSource
Cited By3
Newest
#1Mi-Chun Chou (National Taipei University of Nursing and Health Science)
#2Ching-Hui Chien (National Taipei University of Nursing and Health Science)H-Index: 5
Last. Ying-Hsu Chang (CGU: Chang Gung University)H-Index: 14
view all 8 authors...
Abstract Context The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) has been used in different countries to assess the specific anxiety of patients with prostate cancer. Objectives This research aims to test the reliability and validity of the Taiwanese version of the MAX-PC (MAX-PC-T). Methods Patients with prostate cancer in the urology clinics of three hospitals are recruited via a convenience sampling. Patients completed the MAX-PC-T, Positive and Negative Affect Schedule (PANAS), and t...
Source
Background The psychological burden possibly deriving from not immediately undergoing radical treatment for prostate cancer (PCa) could be a potential disadvantage of active surveillance (AS), especially in the eve of some relevant clinical exams [i.e., re-biopsy, prostate-specific antigen (PSA) test, and medical examination]. Even if it is known from the literature that the majority of PCa men in AS do not report heightened anxiety, there is a minority of patients who show clinically significan...
Source
#1Rajae Touzani (AMU: Aix-Marseille University)H-Index: 3
#2Julien Mancini (AMU: Aix-Marseille University)H-Index: 40
Last. Patricia Marino (AMU: Aix-Marseille University)H-Index: 7
view all 7 authors...
Introduction The Memorial Anxiety Scale for Prostate Cancer (MAX-PC, 18 items) was developed to assess anxiety in prostate cancer patients. In the absence of a French version of this scale, we adapted the original English scale and evaluated its psychometric properties in a sample of French men diagnosed with prostate cancer in the previous 12 months.
1 CitationsSource